US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Horizon Kinetics Blockchain Development ETF

33.16

-0.1125-0.34%

Post-market: 33.270.1125+0.34%16:10 EDT

Volume:201

Turnover:7K

Market Cap:24.04M

PE:- -

High:33.16

Open:33.31

Low:33.16

Close:33.27

52wk High:36.27

52wk Low:29.01

Shares:725.00K

Float Shares:725.00K

Volume Ratio:0.31

T/O Rate:0.03%

Dividend:0.76

Dividend Rate:2.30%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Spirit Blockchain Capital to Rename as Impauer Technologies, Adopt IMPR Ticker

Verde AgriTech Unit Magnes Rare Earths Hits 29 M at 0.58% TREO in First RC Drilling at Minas Americas

Generate Biomedicines Management to Present at Upcoming Investor Conferences

Zenas BioPharma to Host Virtual Obexelimab IgG4-RD Investor Event

NRx Pharma to Present at Moody Capital Solutions Disruptive Growth & Life Sciences Conference

Sernova, Seraxis Agree Merger to Form BetaNova Biotherapeutics

X4 Pharmaceuticals Says FDA Backs Reduced Enrollment Target for 4WARD Phase 3 Chronic Neutropenia Trial

Lightbridge Targets Mid-2030s Lead Test Assemblies Via DOE-Backed SHED Pilot Plant at INL

Lahontan Gold Hires Tony Gesualdo as VP Exploration

Cartesian Therapeutics Grants New Hires Stock Options for 59,700 Shares at USD 9.27 Each

Phoenix Metals Wins Amended Permit to Start Drilling at Greenwood Project in British Columbia

Monte Rosa Says Novartis Starts Phase 2 Trial of MRT-6160 in Sjögren's Disease, Triggers USD 50 Million Milestone

CoinShares Co-Founder Daniel Masters Discloses Plan Cutting Stake to About 15.3% from 16.4%

Vor Bio Completes Enrollment in Phase 3 Upstream MG Trial for Telitacicept in Generalized Myasthenia Gravis

Adlai Nortye Wins FDA IND Clearance for An4035 ADC Trial Expansion to US

Nkarta to Present Initial Phase 1/2 Autoimmune Data for CAR-NK Therapy Nkx019 at ACR Convergence 2026

OKYO Pharma Joins Cantor Global Healthcare Conference Fireside Chat

NetraMark Names Former Global Atlantic Investment Office President Kevin Felix Strategic Advisor

Erasca to Present at Morgan Stanley Global Healthcare Conference

ABM FY26 Q3 Net Income Rises 19% to $49.7 Million; Revenue Increases 4.2% to $2.3 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BCDF/news?page=33"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BCDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","market":"US","secType":"STK","nameCN":"Horizon Kinetics Blockchain Development ETF","latestPrice":33.1605,"timestamp":1789156800000,"preClose":33.273,"halted":0,"volume":201,"hourTrading":{"tag":"盘后","latestPrice":33.273,"preClose":33.1605,"latestTime":"16:10 EDT","volume":4,"amount":132.642,"timestamp":1789157404304,"change":0.1125,"changeRate":0.003393,"amplitude":0},"delay":0,"changeRate":-0.0033811198268867927,"floatShares":725000,"shares":725000,"eps":0,"marketStatus":"Market Closed","change":-0.1125,"latestTime":"09-11 16:00:00 EDT","open":33.31,"high":33.1605,"low":33.1605,"amount":6704,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":33.273,"sharesOutstanding":675000,"nav":33.3,"aum":24142500,"dividendRate":0.022973,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.273,"preClose":33.1605,"latestTime":"16:10 EDT","volume":4,"amount":132.642,"timestamp":1789157404304,"change":0.1125,"changeRate":0.003393,"amplitude":0},"volumeRatio":0.31259719089899873},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","floatShares":725000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.31259719089899873,"shares":725000,"dividePrice":0.7618,"high":33.1605,"amplitude":0,"preClose":33.273,"low":33.1605,"week52Low":29.01,"pbRate":"--","week52High":36.27,"institutionHeld":0,"latestPrice":33.1605,"eps":0,"divideRate":0.022973,"volume":201,"delay":0,"ttmEps":0,"open":33.31,"prevYearClose":30.2172,"prevWeekClose":34.0101,"prevMonthClose":34.115,"prevQuarterClose":29.7995,"fiveDayClose":34.0114,"twentyDayClose":33.2426,"sixtyDayClose":31.5743},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDF\",params:#limit:5,,,undefined,":[{"date":"2024-12-24","symbol":"BCDF","amount":0.45302,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"Horizon Kinetics Blockchain Development ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"BCDF","amount":0.169967,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"},{"market":"US","date":"2022-12-28","symbol":"BCDF","amount":0.05244,"defaultRemindTime":1672237800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2022-09-28","symbol":"BCDF","amount":0.0219,"defaultRemindTime":1664371800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-09-30","payableDate":"2022-09-29","currency":"USD","type":"dividend","dateTimestamp":1664337600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDF\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-28","recordDate":"2022-09-29","paymentDate":"2022-09-30","value":0.0219,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.05244,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.169967,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.45302,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCDF\",pageSize:20,pageCount:33,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665732272","title":"Spirit Blockchain Capital to Rename as Impauer Technologies, Adopt IMPR Ticker","url":"https://stock-news.laohu8.com/highlight/detail?id=2665732272","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665732272?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:15","pubTimestamp":1788866113,"startTime":"0","endTime":"0","summary":"Spirit Blockchain Capital to rename as Impauer Technologies, adopt IMPR tickerSpirit Blockchain Capital will rebrand as Impauer Technologies, pivoting its corporate identity toward a broader technolog","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL5kHBHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014021.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","NDAQ","IE00BN0W2T93.GBP","LU2095319765.USD","BK4588","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","BK4585","BCDF","SG9999014039.USD","IE00BQXX3F31.USD","BK4112","IE00BQXX3D17.EUR","SG9999014005.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322206","title":"Verde AgriTech Unit Magnes Rare Earths Hits 29 M at 0.58% TREO in First RC Drilling at Minas Americas","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322206","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322206?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:13","pubTimestamp":1788865996,"startTime":"0","endTime":"0","summary":"Verde AgriTech unit Magnes Rare Earths hits 29 m at 0.58% TREO in first RC drilling at Minas AmericasVerde Agritech unit Magnes Rare Earths reported first RC drilling assays at its Minas Americas rare","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL8Ywyzg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BCDF","LU0314104364.USD","LU2210149790.SGD","SG9999014021.USD","SG9999014005.SGD","BK4112","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","SG9999014013.SGD","LU2095319765.USD","NDAQ","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","BK4588","IE00BQXX3F31.USD","IE00BGHQF748.EUR","BK4585","SG9999014039.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322443","title":"Generate Biomedicines Management to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322443","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322443?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:09","pubTimestamp":1788865761,"startTime":"0","endTime":"0","summary":"Generate Biomedicines management to present at upcoming investor conferencesGenerate Biomedicines management will present at investor conferences in New York in September.Cantor Global Healthcare Conf","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL7930Tg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4139","IE00BN0W2T93.GBP","LU0251131958.USD","LU2237443382.USD","LU2896262040.SGD","SG9999014021.USD","SG9999014039.USD","LU0096364046.USD","LU2210150020.SGD","GENB","BCDF","LU0868494708.USD","LU2471134796.USD","BK4533","GSX","LU0345770993.USD","LU2471134952.CNY","SG9999014013.SGD","IE00BSNM7G36.USD","LU0868494617.USD","BK4552","LU1144417596.USD","IE00BQXX3C00.GBP","LU0251142724.SGD","LU0345770308.USD","LU0314104364.USD","LU0742534661.SGD","BK4504","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU1868837136.USD","LU1868837300.USD","LU1868836591.USD","LU2750360641.GBP","BK4588","IE00BQXX3F31.USD","LU1894683264.USD","LU2210149790.SGD","IE00BN0W2W23.USD","NDAQ","LU2265009873.SGD","LU2237443895.HKD","IE0002270589.USD","LU0106831901.USD","IE00BFXG1179.USD","LU1791807156.HKD","IE00B19Z3B42.SGD","LU2237443465.HKD","IE0004086264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322486","title":"Zenas BioPharma to Host Virtual Obexelimab IgG4-RD Investor Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322486","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322486?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:06","pubTimestamp":1788865589,"startTime":"0","endTime":"0","summary":"Zenas BioPharma to host virtual obexelimab IgG4-RD investor eventZenas BioPharma will host a virtual obexelimab IgG4-RD investor event on Sept. 29, 2026, from 8:00-9:30 a.m. ET.Session will cover IgG4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL7NMmdF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BQXX3F31.USD","IE00BN0W2W23.USD","LU0314104364.USD","BK4588","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","LU2210149790.SGD","ZBIO","BK4112","IE00BN0W2V16.EUR","LU2095319765.USD","NDAQ","SG9999014039.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","SG9999014021.USD","IE00BKPKM429.USD","SG9999014005.SGD","BK4139","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322488","title":"NRx Pharma to Present at Moody Capital Solutions Disruptive Growth & Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322488","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322488?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:06","pubTimestamp":1788865578,"startTime":"0","endTime":"0","summary":"NRx Pharma to present at Moody Capital Solutions Disruptive Growth & Life Sciences ConferenceNRx Pharmaceuticals management will present at investor conferences in New York on Sept. 9, Sept. 11, Sept.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1TRKCH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","NDAQ","IE00BQXX3C00.GBP","LU0314104364.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014005.SGD","BCDF","CFSU","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","SG9999014013.SGD","IE00BN0W2T93.GBP","PSIL","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU2095319765.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665489322","title":"Sernova, Seraxis Agree Merger to Form BetaNova Biotherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2665489322","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665489322?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:06","pubTimestamp":1788865563,"startTime":"0","endTime":"0","summary":"Sernova, Seraxis agree merger to form BetaNova BiotherapeuticsSernova Biotherapeutics agreed to merge with Seraxis to form BetaNova Biotherapeutics, a type 1 diabetes islet cell-replacement developer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4RlvDx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","BK4112","SG9999014005.SGD","IE00BQXX3F31.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","NDAQ","IE00BGHQF748.EUR","BCDF","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585","LU0314104364.USD","BK4588","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322142","title":"X4 Pharmaceuticals Says FDA Backs Reduced Enrollment Target for 4WARD Phase 3 Chronic Neutropenia Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322142","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322142?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:05","pubTimestamp":1788865554,"startTime":"0","endTime":"0","summary":"X4 Pharmaceuticals says FDA backs reduced enrollment target for 4WARD Phase 3 chronic neutropenia trialX4 Pharmaceuticals reached alignment with the FDA to cut enrollment in its 4WARD Phase 3 trial of","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3cWCw9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XFOR","BK4588","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BKPKM429.USD","BCDF","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","BK4112","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","LU2095319765.USD","NDAQ","SG9999014039.USD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4139","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665432214","title":"Lightbridge Targets Mid-2030s Lead Test Assemblies Via DOE-Backed SHED Pilot Plant at INL","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665432214?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:04","pubTimestamp":1788865499,"startTime":"0","endTime":"0","summary":"Lightbridge targets mid-2030s lead test assemblies via DOE-backed SHED pilot plant at INLLightbridge set a two-track commercialization plan to accelerate Lightbridge Fuel deployment, following selecti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL56nF43:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4156","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210149790.SGD","BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BKPKM429.USD","SG9999014005.SGD","NDAQ","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","BK4112","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4588","BK4585","IE00BN0W2W23.USD","SG9999014021.USD","LTBR","SG9999014013.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322901","title":"Lahontan Gold Hires Tony Gesualdo as VP Exploration","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322901","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322901?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:04","pubTimestamp":1788865478,"startTime":"0","endTime":"0","summary":"Lahontan Gold hires Tony Gesualdo as VP explorationLahontan Gold hired Tony Gesualdo as vice president of exploration as it shifts from developer to mine builder.Gesualdo was previously senior explora","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL54jlXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","BK4585","MUX","IE00BQXX3D17.EUR","BK4017","SG9999014013.SGD","LU0314104364.USD","SG9999014021.USD","BCDF","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SLJY","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2210149790.SGD","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665132213","title":"Cartesian Therapeutics Grants New Hires Stock Options for 59,700 Shares at USD 9.27 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2665132213","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665132213?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:04","pubTimestamp":1788865466,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics grants new hires stock options for 59,700 shares at USD 9.27 eachCartesian Therapeutics granted stock options covering 59,700 shares to three new employees under its 2018 employ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2YgZhB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NDAQ","BCDF","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2W23.USD","BK4112","BK4588","IE00BKPKM429.USD","BK4139","IE00BQXX3F31.USD","LU2210149790.SGD","IE00B64PRP62.GBP","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","RNAC","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322154","title":"Phoenix Metals Wins Amended Permit to Start Drilling at Greenwood Project in British Columbia","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322154","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322154?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:04","pubTimestamp":1788865459,"startTime":"0","endTime":"0","summary":"Phoenix Metals wins amended permit to start drilling at Greenwood project in British ColumbiaPhoenix Metals received an amended BC exploration permit for its Greenwood project in British Columbia, cle","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL5nP8cQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","BK4585","IE00BQXX3D17.EUR","SG9999014013.SGD","LU0314104364.USD","SG9999014021.USD","BCDF","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2210149790.SGD","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665221523","title":"Monte Rosa Says Novartis Starts Phase 2 Trial of MRT-6160 in Sjögren's Disease, Triggers USD 50 Million Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2665221523","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665221523?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:04","pubTimestamp":1788865455,"startTime":"0","endTime":"0","summary":"Monte Rosa says Novartis starts Phase 2 trial of MRT-6160 in Sjgren's disease, triggers USD 50 million milestoneNovartis initiated a Phase 2 study of VAV1-directed molecular glue degrader MRT-6160 (DD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbDCbtF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BQXX3C00.GBP","SG9999014005.SGD","BK4585","BK4539","BK4112","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014013.SGD","BK4588","IE00BN0W2W23.USD","GLUE","BCDF","SG9999014039.USD","LU0314104364.USD","LU2210150020.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","BK4139","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322970","title":"CoinShares Co-Founder Daniel Masters Discloses Plan Cutting Stake to About 15.3% from 16.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322970","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322970?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865434,"startTime":"0","endTime":"0","summary":"CoinShares co-founder Daniel Masters discloses plan cutting stake to about 15.3% from 16.4%CoinShares co-founder Daniel Masters adopted a Rule 10b5-1 plan that could cut his reported stake to about 15","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL8Jqq9L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","LU0314104364.USD","SG9999014005.SGD","IE00BQXX3F31.USD","IE00BN0W2W23.USD","NDAQ","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","BK4588","IE00BQXX3D17.EUR","SG9999014021.USD","CSHR","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210150020.SGD","BK4112","SG9999014013.SGD","BK4135","BCDF","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322904","title":"Vor Bio Completes Enrollment in Phase 3 Upstream MG Trial for Telitacicept in Generalized Myasthenia Gravis","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322904","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322904?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865388,"startTime":"0","endTime":"0","summary":"Vor Bio completes enrollment in Phase 3 UPSTREAM MG trial for telitacicept in generalized myasthenia gravisVor Bio completed enrollment in its global Phase 3 UPSTREAM MG trial of telitacicept in gener","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2P1gph:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","VOR","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BKPKM429.USD","BCDF","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","BK4112","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","LU2095319765.USD","NDAQ","SG9999014039.USD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4139","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665229773","title":"Adlai Nortye Wins FDA IND Clearance for An4035 ADC Trial Expansion to US","url":"https://stock-news.laohu8.com/highlight/detail?id=2665229773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665229773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865381,"startTime":"0","endTime":"0","summary":"Adlai Nortye wins FDA IND clearance for AN4035 ADC trial expansion to USAdlai Nortye received U.S. FDA IND clearance for AN4035, enabling its Phase I trial to expand into the U.S.First patient dosed i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL21sYH0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","LU2133065610.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BGHQF748.EUR","BCDF","BK4112","SG9999014005.SGD","BK4588","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","SG9999014021.USD","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","BK4139","LU2095319765.USD","IE00BZ199S13.USD","BK4585","ANL","NDAQ","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665960322","title":"Nkarta to Present Initial Phase 1/2 Autoimmune Data for CAR-NK Therapy Nkx019 at ACR Convergence 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665960322","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665960322?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:01","pubTimestamp":1788865267,"startTime":"0","endTime":"0","summary":"Nkarta to present initial Phase 1/2 autoimmune data for CAR-NK therapy NKX019 at ACR Convergence 2026Nkarta flagged initial Phase 1/2 clinical readouts for CAR-NK therapy NKX019 across autoimmune dise","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL74Wb3Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210149790.SGD","LU2210150020.SGD","SG9999014021.USD","IE00BN0W2T93.GBP","BK4139","BCDF","IE00BQXX3C00.GBP","LU0314104364.USD","IE00BKPKM429.USD","NKTX","IE00BGHQF748.EUR","NDAQ","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4588","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00BQXX3F31.USD","BK4585","SG9999014039.USD","SG9999014013.SGD","BK4505","IE00B3QW5Z07.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322636","title":"OKYO Pharma Joins Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322636","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322636?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865245,"startTime":"0","endTime":"0","summary":"OKYO Pharma joins Cantor Global Healthcare Conference fireside chatOKYO Pharma will join the Cantor Global Healthcare Conference on Sept. 9-11, 2026.A fireside chat is set for Sept. 10 at 8:35 a.m. ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL85Lc15:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BQXX3C00.GBP","IE00BKPKM429.USD","BK4139","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00BQXX3F31.USD","BCDF","IE00B64PRP62.GBP","OKYO","LU2095319765.USD","LU0314104364.USD","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","BK4585","LU2210150020.SGD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4588","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232263","title":"NetraMark Names Former Global Atlantic Investment Office President Kevin Felix Strategic Advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232263","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232263?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865237,"startTime":"0","endTime":"0","summary":"NetraMark names former Global Atlantic investment office president Kevin Felix strategic advisorNetraMark appointed former Global Atlantic Investment Office President Kevin Felix as strategic advisor ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc45mFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","BK4585","SG9999014021.USD","LU1935043536.SGD","LU0980610538.SGD","IE00B64PRP62.GBP","BCDF","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","KKR","NDAQ","PRVT","LU1668664300.SGD","LU1935042991.SGD","LU1791807156.HKD","PSP","AAUM","IE00BN0W2T93.GBP","IE00BQXX3F31.USD","SG9999014013.SGD","SG9999014005.SGD","LU1935042215.USD","IE00BN0W2W23.USD","LU2095319765.USD","IE00BGHQF748.EUR","LU0106831901.USD","GPZ","LU2210149790.SGD","LU2210150020.SGD","BK4112","LU1201861249.SGD","SG9999014039.USD","BK4588","LU1935043023.USD","LBO","LU0130102774.USD","LU0648001328.SGD","LU1935042488.USD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4135","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532268","title":"Erasca to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532268","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532268?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865217,"startTime":"0","endTime":"0","summary":"Erasca to present at Morgan Stanley Global Healthcare ConferenceErasca will attend the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 15, 2026 in New York.Management is scheduled for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL8MxbT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU1989772840.SGD","LU2210149790.SGD","BK4516","IE00BKVL7J92.USD","LU0006306889.USD","LU2111349929.HKD","IAI","LU0234570918.USD","LU2133065610.SGD","LU2264538146.SGD","LU0158827781.USD","IE00B3S45H60.SGD","BK4504","SG9999014005.SGD","LU0528227936.USD","LU1720051108.HKD","SG9999014039.USD","LU1074936037.SGD","BK4581","IE00BQXX3D17.EUR","LU0971096721.USD","LU0557290698.USD","LU1244550494.USD","LU1548497426.USD","IE00BKPKM429.USD","LU1720051017.SGD","BCDF","IE00BN0W2T93.GBP","LU1244550221.USD","LU1989772923.USD","BK4534","IE00B775SV38.USD","IE00BGHQF748.EUR","BK4139","IE00BN0W2W23.USD","LU0106261372.USD","LU0210528500.USD","LU1244550577.SGD","LU1988902786.USD","NDAQ","SG9999014013.SGD","LU2028103732.USD","LU1732800096.USD","LU0314104364.USD","ERAS","LU1162221912.USD","KBWB","LU2487616109.SGD","LU0882574139.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665228233","title":"ABM FY26 Q3 Net Income Rises 19% to $49.7 Million; Revenue Increases 4.2% to $2.3 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2665228233","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665228233?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:58","pubTimestamp":1788865113,"startTime":"0","endTime":"0","summary":"ABM FY26 Q3 net income rises 19% to $49.7 million; revenue increases 4.2% to $2.3 billionABM posted fiscal Q3 revenue up 4.2% to $2.3 billion, a quarterly record, including 2.1% organic growth.GAAP ne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbpf2ht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","LU1878469433.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","ABM","BK4120","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","BK4112","SG9999014005.SGD","IE00BQXX3F31.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","NDAQ","IE00BGHQF748.EUR","BCDF","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585","LU0314104364.USD","BK4588","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":78,"pageCount":33,"totalSize":1546,"code":"91000000","status":"200"}]}}